Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Completed
×
acalabrutinib
×
Clear all
Filters
3
NCT04008706
2025-12-01
ASSURE
AstraZeneca
Phase 3
Completed
552 enrolled